These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18541899)

  • 1. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.
    Hamstra DA; Galbán CJ; Meyer CR; Johnson TD; Sundgren PC; Tsien C; Lawrence TS; Junck L; Ross DJ; Rehemtulla A; Ross BD; Chenevert TL
    J Clin Oncol; 2008 Jul; 26(20):3387-94. PubMed ID: 18541899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of conformal radiation therapy for pediatric low-grade glioma.
    Merchant TE; Kun LE; Wu S; Xiong X; Sanford RA; Boop FA
    J Clin Oncol; 2009 Aug; 27(22):3598-604. PubMed ID: 19581536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map.
    Hiramatsu R; Kawabata S; Furuse M; Miyatake S; Kuroiwa T
    Radiat Oncol; 2013 Aug; 8(1):192. PubMed ID: 23915330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.
    Galbán CJ; Chenevert TL; Meyer CR; Tsien C; Lawrence TS; Hamstra DA; Junck L; Sundgren PC; Johnson TD; Galbán S; Sebolt-Leopold JS; Rehemtulla A; Ross BD
    Clin Cancer Res; 2011 Jul; 17(14):4751-60. PubMed ID: 21527563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Voxel-Wise and Histogram Analyses of Glioma ADC Maps for Prediction of Early Therapeutic Change.
    Chenevert TL; Malyarenko DI; Galbán CJ; Gomez-Hassan DM; Sundgren PC; Tsien CI; Ross BD
    Tomography; 2019 Mar; 5(1):7-14. PubMed ID: 30854437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits.
    Merchant TE; Conklin HM; Wu S; Lustig RH; Xiong X
    J Clin Oncol; 2009 Aug; 27(22):3691-7. PubMed ID: 19581535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.
    Hamstra DA; Chenevert TL; Moffat BA; Johnson TD; Meyer CR; Mukherji SK; Quint DJ; Gebarski SS; Fan X; Tsien CI; Lawrence TS; Junck L; Rehemtulla A; Ross BD
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16759-64. PubMed ID: 16267128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
    Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
    Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy.
    Chung C; Jalali S; Foltz W; Burrell K; Wildgoose P; Lindsay P; Graves C; Camphausen K; Milosevic M; Jaffray D; Zadeh G; Ménard C
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):805-12. PubMed ID: 22929856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis of the patients with high-grade gliomas.
    Wang X; Gao W; Li F; Shi W; Li H; Zeng Q
    Magn Reson Imaging; 2019 Nov; 63():131-136. PubMed ID: 31425809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from 2D conventional to 3d conformal radiation therapy in patients with brain gliomas: clinical outcome (Mansoura University).
    Awad IA; El-Kholi NM; El-Lithy MA; Hendawi EA; Anter AH
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):133-8. PubMed ID: 21057564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide in the treatment of recurrent malignant glioma.
    Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
    Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance.
    Claus EB; Horlacher A; Hsu L; Schwartz RB; Dello-Iacono D; Talos F; Jolesz FA; Black PM
    Cancer; 2005 Mar; 103(6):1227-33. PubMed ID: 15690327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
    Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting outcome of patients with high-grade gliomas after radiotherapy using quantitative analysis of T1-weighted magnetic resonance imaging.
    Tsien C; Gomez-Hassan D; Chenevert TL; Lee J; Lawrence T; Ten Haken RK; Junck LR; Ross B; Cao Y
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1476-83. PubMed ID: 17276619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter.
    Ramnarayan R; Dodd S; Das K; Heidecke V; Rainov NG
    J Neurol Sci; 2007 Sep; 260(1-2):49-56. PubMed ID: 17475281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.
    Ellingson BM; Cloughesy TF; Zaw T; Lai A; Nghiemphu PL; Harris R; Lalezari S; Wagle N; Naeini KM; Carrillo J; Liau LM; Pope WB
    Neuro Oncol; 2012 Mar; 14(3):333-43. PubMed ID: 22270220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study.
    Hempel JM; Brendle C; Bender B; Bier G; Kraus MS; Skardelly M; Richter H; Eckert F; Schittenhelm J; Ernemann U; Klose U
    Eur J Radiol; 2019 Mar; 112():144-152. PubMed ID: 30777204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
    Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
    Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.